Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615378 · ClinicalTrials.gov registry record · Early Phase 1
Maintenance Dosing of Vitamin D in Crohn's Disease
A Early Phase 1 study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT03615378 is a Early Phase 1 study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT03615378, a Early Phase 1 study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Vitamin D repletion is important for bone health in patients with Crohn's disease. While repletion strategies in the general population yield similar results in those with Crohn's disease, maintenance strategies are variable. High quality evidence is lacking to determine the optimal strategy to maintain adequate levels of Vitamin D levels in patients with Crohn's disease.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 5000 IU D3
- DIETARY_SUPPLEMENT 1000 IU D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-08-30 |
| Est. Completion | 2018-11-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03615378
The ClinicalTrials.gov registry entry for NCT03615378 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03615378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03615378 about?
NCT03615378 is a clinical study titled "Maintenance Dosing of Vitamin D in Crohn's Disease". Vitamin D repletion is important for bone health in patients with Crohn's disease. While repletion strategies in the general population yield similar results in those with Crohn's disease, maintenance strategies are variable. High quality evidence is lacking to determine the optimal strategy to main...
What is the current status of trial NCT03615378?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2018-08-30. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT03615378?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 5000 IU D3 (DIETARY_SUPPLEMENT), 1000 IU D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03615378?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.